News & Perspective

Jun 01, 2011

Jun 01, 2011

E coli cases, deaths in Europe push higher

(CIDRAP News) – The count of cases and deaths in Europe's Escherichia coli outbreak pushed higher today, with various news reports citing about 1,500 cases and 17 deaths, while the source of the epidemic remained a mystery.

Nov 11, 2010

Nov 11, 2010

Canada finds more infections with NDM-1 resistance factor

(CIDRAP News) – A recently identified enzyme that can make gram-negative bacteria resistant to nearly all antibiotics is back in the news with reports of several recent cases in Canada and two in Austria.

Oct 06, 2010

Oct 06, 2010

Trial answers some, not all, questions on cell-based flu vaccines

(CIDRAP News) – A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.

May 01, 2009

May 01, 2009

SWINE FLU BREAKING NEWS: Case counts, antiviral purchase, worried patients, Mexico timeline, 300 US schools close, Hong Kong quarantine

 

The World Health Organization (WHO) reported 331 cases of swine influenza H1N1 in 11 countries as of 6 a.m. GMT today. The case numbers by country are United States, 109 (1 death) (these are yesterday's totals); Mexico, 156 (9 deaths), Canada, 34; Spain, 13; United Kingdom, 8; New Zealand, 3; Germany, 3; Israel, 2; and 1 each in Austria, the Netherlands, and Switzerland. [WHO update 7]

Apr 29, 2009

Apr 29, 2009

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Jun 12, 2008

Jun 12, 2008

Baxter says cell-based H5N1 vaccine did well in trial

(CIDRAP News) – A pharmaceutical company is reporting good results in the first clinical trial of an H5N1 avian influenza vaccine that uses a whole, killed H5N1 virus grown in cell culture—a combination of techniques that entails some risk but may boost immune response and shorten production time.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»